New therapies that specifically target inflammatory pathways or aberrant physiology in severe asthma offer substantial opportunities for effective treatment. Some of these therapies are available under specialist referral, and others are available in the context of clinical trials.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Respirology - Malaysia digital copy today!
Single doses of the small-molecule prodrug baloxavir marboxil (hereafter baloxavir) was effective in alleviating influenza symptoms and superior to oseltamivir in reducing infectious viral load within 1 day after initiating treatment in people with uncomplicated influenza, results of two randomized trials show.